Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Budhu Website

Anuradha S. Budhu, Ph.D.

Selected Publications

1)  Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW.
Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.
Gastroenterology. 144: 1066-1075.e1, 2013.
2)  Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW.
MicroRNA expression, survival, and response to interferon in liver cancer.
N. Engl. J. Med. 361: 1437-47, 2009.
3)  Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW.
Identification of metastasis-related microRNAs in hepatocellular carcinoma.
Hepatology. 47: 897-907, 2008.
4)  Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW.
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.
Cancer Cell. 10: 99-111, 2006.
5)  Wang W, Budhu A, Forgues M, Wang XW.
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Nat. Cell Biol. 7: 823-30, 2005.
6)  Dang HT, Budhu A, Wang XW.
The origin of cancer stem cells.
J. Hepatol. [Epub ahead of print], 2014.
7)  Henrich CJ, Budhu A, Yu Z, Evans JR, Goncharova EI, Ransom TT, Wang XW, McMahon JB.
High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.
Chem Biol Drug Des. 82: 131-9, 2013.
8)  Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP.
Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
Clin. Cancer Res. 19: 4983-93, 2013.
9)  Budhu A, Wang XW.
At the cancer steering wheel: defining key genomic drivers of liver cancer with next generation sequencing.
J. Hepatol. 56: 1412-4, 2012.
10)  Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, Tang ZY, He P, Hunter KW, Thorgeirsson SS, Meltzer PS, Wang XW.
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
Gastroenterology. 142: 957-966.e12, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 7/11/2014.